Published in
Taylor and Francis Group, Leukemia & Lymphoma, 2(59), p. 357-362
DOI: 10.1080/10428194.2017.1330954
Links
Tools
Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study
Journal article published in 2017 by
Sagun Goyal,
Eunhye Oak,
Jingqin Luo,
Cashen Af,
Amanda F. Cashen,
Kenneth Carson,
Nina D. Wagner-Johnston,
Todd Fehniger,
John DiPersio,
Nancy L. Bartlett 
,
Bartlett Nl,
Wagner Johnston Nd
,
Bartlett Nl,
Wagner Johnston Nd
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 